US 10604807
Methods for diagnosing and assessing treatment for Cushing's syndrome
granted A61KA61K31/4745A61K31/567
Quick answer
US patent 10604807 (Methods for diagnosing and assessing treatment for Cushing's syndrome) held by Corcept Therapeutics Incorporated expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/4745, A61K31/567, A61K31/573, A61K45/06